Corporate calendar for Bionano Genomics, Inc. (BNGO): upcoming earnings dates, dividend ex-dates and payment dates, stock splits, shareholder meetings and conference calls. Plan your positions around the key catalysts.
Bionano Genomics, Inc. focuses on providing advanced solutions for analyzing genomes. The company's flagship offering is Saphyr, a complete system that processes samples to results, enabling the analysis of structural variations in the genome using optical genome mapping. This technology is vital for deciphering genetic variations and their functional roles.
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|---|---|
| 2026-09-15 | ||
| 2026-09-15 | ||
| 2026-09-15 | $0.05 | $88M |
| 2026-09-15 | ||
| 2026-09-15 | $0.14 | $2.28B |
| 2026-09-15 |
Price
| Price | $1.51 |
| Market Cap | $17M |
| Exchange | NASDAQ |
| Country | US |
Analyst Consensus
| Strong Buy | 0 |
| Buy | 4 |
| Hold | 3 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 7 |
| Avg rating (1-5) | 0.57 |
Related companies: AIM · BNBX · GBS · KTTA · MYNZ · NDRA · POAI
Explore sector: Healthcare · Medical - Instruments & Supplies
More sections of BNGO: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · News
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks